Pfizer estimates $15 bn in 2021 sales for COVID-19 vaccine
AFP
1612268299000

A healthcare professional draws up a dose of Pfizer/BioNTech COVID-19 vaccine to be adminstered at a vaccination centre set up at Thornton Little Theatre managed by Wyre Council in Thornton-Cleveleys, northwest England, on January 29, 2021. (Phtoto: AFP)

Sales of the COVID-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday.

The projections came as Pfizer reported fourth-quarter and full-year profits and released forecasts for 2021. Pfizer projected full-year 2021 sales of between $44.4 to $46.4 billion, excluding sales for the COVID-19 vaccine.